DexCom/$DXCM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About DexCom
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Ticker
$DXCM
Sector
Primary listing
Employees
11,050
Headquarters
Website
DexCom Metrics
BasicAdvanced
$25B
30.74
$2.09
1.49
-
Price and volume
Market cap
$25B
Beta
1.49
52-week high
$89.98
52-week low
$54.11
Average daily volume
4.7M
Financial strength
Current ratio
1.883
Quick ratio
1.535
Long term debt to equity
47.862
Total debt to equity
50.852
Interest coverage (TTM)
49.83%
Profitability
EBITDA (TTM)
1,163.6
Gross margin (TTM)
60.10%
Net profit margin (TTM)
17.94%
Operating margin (TTM)
19.62%
Effective tax rate (TTM)
23.16%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
8.91%
Return on equity (TTM)
34.50%
Valuation
Price to earnings (TTM)
30.744
Price to revenue (TTM)
5.377
Price to book
9
Price to tangible book (TTM)
9.32
Price to free cash flow (TTM)
23.27
Free cash flow yield (TTM)
4.30%
Free cash flow per share (TTM)
2.761
Growth
Revenue change (TTM)
15.60%
Earnings per share change (TTM)
46.73%
3-year revenue growth (CAGR)
17.01%
10-year revenue growth (CAGR)
27.77%
3-year earnings per share growth (CAGR)
36.37%
10-year earnings per share growth (CAGR)
27.75%
What the Analysts think about DexCom
Analyst ratings (Buy, Hold, Sell) for DexCom stock.
DexCom Financial Performance
Revenues and expenses
DexCom Earnings Performance
Company profitability
DexCom News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for DexCom stock?
DexCom (DXCM) has a market cap of $25B as of March 16, 2026.
What is the P/E ratio for DexCom stock?
The price to earnings (P/E) ratio for DexCom (DXCM) stock is 30.74 as of March 16, 2026.
Does DexCom stock pay dividends?
No, DexCom (DXCM) stock does not pay dividends to its shareholders as of March 16, 2026.
When is the next DexCom dividend payment date?
DexCom (DXCM) stock does not pay dividends to its shareholders.
What is the beta indicator for DexCom?
DexCom (DXCM) has a beta rating of 1.49. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.